18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study.

Journal: Cancers
Published Date:

Abstract

PURPOSE: This bi-centric pilot study investigates the predictive value of pre-treatment [F]FDG PET/CT radiomics for assessing therapy response in primary mediastinal B-cell lymphoma (PMBCL).

Authors

  • Fabiana Esposito
    Hematology, Department of Biomedicine and Prevention, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Luigi Manco
    A.O. U. di Modena, Medical Physics Unit, Modena, Italy.
  • Luca Urso
    Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Sara Adamantiadis
    Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Giovanni Scribano
    Department of Physics and Earth Science, University of Ferrara, Ferrara, Italy.
  • Lucrezia De Marchi
    Hematology, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Adriano Venditti
    Hematology, Department of Biomedicine and Prevention, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Massimiliano Postorino
    Hematology, Department of Biomedicine and Prevention, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Nicoletta Urbano
    Nuclear Medicine Unit, Department of Oncohaematology, Policlinico "Tor Vergata", viale oxford 81, 00133, Rome, Italy.
  • Roberta Gafà
    Department of Translational Medicine, University of Ferrara, 44124 Ferrara, Italy.
  • Antonio Cuneo
    Hematology Unit, University of Ferrara, 44121 Ferrara, Italy.
  • Agostino Chiaravalloti
    Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
  • Mirco Bartolomei
    Nuclear Medicine Unit, Onco-Hematology Department, University Hospital of Ferrara, Via Aldo Moro 8, 44124, Ferarra, Italy.
  • Luca Filippi
    Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.

Keywords

No keywords available for this article.